Filter Results:
(57)
Show Results For
- All HBS Web
(136)
- People (1)
- News (52)
- Research (57)
- Events (1)
- Multimedia (5)
- Faculty Publications (29)
Show Results For
- All HBS Web
(136)
- People (1)
- News (52)
- Research (57)
- Events (1)
- Multimedia (5)
- Faculty Publications (29)
←
Page 3 of 57
Results
Sort by
- 18 Jul 2018
- Research & Ideas
No More General Tso's? A Threat to 'Knowledge Recombination'
pharmaceutical companies, which had been flying in scientists from China and India who, like Cohly, brought knowledge of native herbs. Some pharma companies were able to earn exemptions from the H1-B limits. Choudhury and Kim used this... View Details
- 09 Aug 2010
- Research & Ideas
How to Speed Up Energy Innovation
Is there a special sauce for stimulating innovation in the energy sector, a concoction to spur cost-effective developments toward solving the climate change problem? HBS professor Rebecca Henderson doesn't claim to know all the ingredients for that special sauce. But... View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
science-based research is something the heads of top biotech and pharmas learned long ago: There are few instant payoffs to please investors. Just ask Raymond Gilmartin, former chairman, president, and CEO of Merck & Co., who now... View Details
- 24 Jul 2018
- First Look
New Research and Ideas, July 24, 2018
pharma company founded by Darwazah’s father in 1978 and traces the evolution of its governance as a private family company, then as a publicly traded company listed on the London Stock Exchange in 2005, and finally as a member of the FTSE... View Details
Keywords: Dina Gerdeman
- 31 May 2011
- First Look
First Look: May 31
within domestic Chinese companies, so he has turned to global multinational pharma companies, for now. The purpose of the case is to help present and future managers at global multinationals who have responsibility for R&D strategy to... View Details
Keywords: Sean Silverthorne
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
that. The fourth piece was executive education. Two years ago we launched an executive education program specifically for future leaders in pharma and biotech. And we've run it for the second year in a row this year. It's a very... View Details
- 21 Jun 2011
- First Look
First Look: June 21
ecosystem. Purchase this note:http://cb.hbsp.harvard.edu/cb/product/911066-PDF-ENG Cipla 2011 Rohit Deshpandé, Sandra J. Sucher, and Laura WinigHarvard Business School Case 511-050 Dr. Yusuf Hamied, head of the Indian pharma and generics... View Details
Keywords: Sean Silverthorne
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
brand over another based on their patients' requests? A recent study, Physicians Report on Patient Encounters Involving Direct to Consumer Advertising, focused on one aspect of pharma DCTA: What do physicians think about all of this? What... View Details
Keywords: by Manda Salls
- 31 May 2016
- First Look
May 31, 2016
https://cb.hbsp.harvard.edu/cbmp/product/516006-PDF-ENG Harvard Business School Case 316-162 Reimagining Capitalism: Towards a Theory of Change No abstract available. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/316162-PDF-ENG Harvard Business School... View Details
Keywords: Sean Silverthorne
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
M&A team decided to achieve this goal through targeted transactions or “precision M&A.” By 2014, after examining 20 or so possible deals, the company was in the process of negotiating a multibillion dollar asset swap with Glaxo-Smith Kline (GSK) that was... View Details
Keywords: Carmen Nobel
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Transformation at Eli Lilly & Co. (A) Faced with the imminent loss of 40% of its revenues due to patent expirations, pharma giant Eli Lilly sets out on a dramatic transformation process in 2009. The case considers how Lilly... View Details
Keywords: Sean Silverthorne
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
development through individual contracts, the comprehensive platform would be free to doctors and pharma alike and financed via an aggressive fundraising strategy and through the sale of the prescription data collected on the app. Barry... View Details
Keywords: Sean Silverthorne
- 29 Apr 2014
- First Look
First Look: April 29
Harvard Business School Case 413-096 Novartis: Leading a Global Enterprise Novartis, the world's leading health care company, was formed in 1996 out of a merger of two very different, mid-tier Switzerland-based pharma companies. The case... View Details
Keywords: Sean Silverthorne
- 14 Aug 2018
- First Look
First Look at New Research and Ideas, August 14, 2018
gene therapy startup. It was spun out of The Children’s Hospital of Philadelphia (CHOP). The company had taken with it much of the intellectual property and talent that CHOP had developed and is considering an initial public offering. In addition, several large View Details
Keywords: by Sean Silverthorne
- 08 Aug 2017
- First Look
First Look at Research and Ideas, August 8, 2017
School Case 415-013 Novartis Pharmaceuticals Corp: Redefining Success in the U.S. (A) Over the course of a tumultuous weekend in April 2010, André Wyss was put in charge of Novartis Pharmaceuticals Corporation (NPC), the U.S. sales and marketing subsidiary of Novartis... View Details
Keywords: Sean Silverthorne
- 04 Apr 2019
- Cold Call Podcast
Can Mark Zuckerberg Rebuild Trust in Facebook?
they're getting great results because of leadership. I think it's time for Mark Zuckerberg and Sheryl Sandberg to step up to leadership. Industries do not do a good job of self-regulation, so we have regulatory bodies. We don’t let pharma... View Details
Keywords: Re: Andi Wang